Sigma Planning Corp Gt Biopharma, Inc. Transaction History

Sigma Planning Corp

  • $3.22 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023
SELL
$0.22 - $0.55 $550 - $1,375
-2,500 Reduced 10.92%
20,395 $6,000
Q1 2023

May 05, 2023
BUY
$0.46 - $1.05 $690 - $1,575
1,500 Added 7.01%
22,895 $12,000
Q3 2022

Nov 10, 2022
SELL
$1.81 - $56.1 $9 - $280
-5 Reduced 0.02%
21,395 $38,000
Q1 2022

Apr 20, 2022
BUY
$2.6 - $3.3 $55,640 - $70,620
21,400 New
21,400 $62,000

Others Institutions Holding GTBP

# of Institutions
4
Shares Held
564
Call Options Held
0
Put Options Held
0
View Full List

About GT Biopharma, Inc.

GTBP Quotes by TradingView
  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $96.4M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email